Adipotide

Fat LossResearch Use Only

Also known as: FTPP, prohibitin-targeting peptide, CKGGRAKDC-GG-D(KLAKLAK)2

Adipotide is an experimental targeting peptide referenced in preclinical fat-tissue research literature. Studies describe a mechanism involving the vasculature supplying white adipose tissue in animal models. It remains an early-stage research compound with limited human data.

Typical range (research)

Referenced only in preclinical/animal research contexts; no established human reference range

Half-life

Short (reported in preclinical data)

Route

Subcutaneous (research)

Common use

Preclinical adipose-tissue research

Common vial sizes

10 mg

Storage

Store lyophilized powder refrigerated (2–8°C) and protected from light; once reconstituted, keep refrigerated and use within the timeframe supported by stability data.

Stacking notes

Early-stage research compound; combination use is not characterized in the literature.

Reported side effects

Renal effects reported in animal studiesDehydration signs in preclinical models

Regulatory note: Not approved for human use in Canada or the US; experimental compound studied primarily in animal models. Research-grade material is not for human use.

Calculate a dose →

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Not for human or veterinary use. Consult a licensed physician.